61 related articles for article (PubMed ID: 26042542)
1. Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs.
Ravera M; Gabano E; Zanellato I; Bonarrigo I; Alessio M; Arnesano F; Galliani A; Natile G; Osella D
J Inorg Biochem; 2015 Sep; 150():1-8. PubMed ID: 26042542
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of Pt(IV) fluorescein conjugates to investigate Pt(IV) intracellular transformations.
Song Y; Suntharalingam K; Yeung JS; Royzen M; Lippard SJ
Bioconjug Chem; 2013 Oct; 24(10):1733-40. PubMed ID: 23957697
[TBL] [Abstract][Full Text] [Related]
3. Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts.
Zhao Y; Woods JA; Farrer NJ; Robinson KS; Pracharova J; Kasparkova J; Novakova O; Li H; Salassa L; Pizarro AM; Clarkson GJ; Song L; Brabec V; Sadler PJ
Chemistry; 2013 Jul; 19(29):9578-91. PubMed ID: 23733242
[TBL] [Abstract][Full Text] [Related]
4. Platinum(IV) Complexes of
Papadia P; Micoli K; Barbanente A; Ditaranto N; Hoeschele JD; Natile G; Marzano C; Gandin V; Margiotta N
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230896
[TBL] [Abstract][Full Text] [Related]
5. Multiaction Pt(IV) Prodrugs Releasing Cisplatin and Dasatinib Are Potent Anticancer and Anti-Invasive Agents Displaying Synergism between the Two Drugs.
Markova L; Maji M; Kostrhunova H; Novohradsky V; Kasparkova J; Gibson D; Brabec V
J Med Chem; 2024 Jun; 67(11):9745-9758. PubMed ID: 38819023
[TBL] [Abstract][Full Text] [Related]
6. Promising Anticancer Prodrugs Based on Pt(IV) Complexes with Bis-organosilane Ligands in Axial Positions.
Navas F; Chocarro-Calvo A; Iglesias-Hernández P; Fernández-García P; Morales V; García-Martínez JM; Sanz R; De la Vieja A; García-Jiménez C; García-Muñoz RA
J Med Chem; 2024 Apr; 67(8):6410-6424. PubMed ID: 38592014
[TBL] [Abstract][Full Text] [Related]
7. Light-Responsive Pt(IV) Prodrugs with Controlled Photoactivation and Low Dark Toxicity.
Spector D; Bubley A; Zharova A; Bykusov V; Skvortsov D; Ipatova D; Erofeev A; Gorelkin P; Vaneev A; Mazur D; Nikitina V; Melnikov M; Pergushov V; Bunin D; Kuzmin V; Kostyukov A; Egorov A; Beloglazkina E; Akasov R; Krasnovskaya O
ACS Appl Bio Mater; 2024 May; 7(5):3431-3440. PubMed ID: 38697834
[TBL] [Abstract][Full Text] [Related]
8. Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery.
Zheng YR; Suntharalingam K; Johnstone TC; Yoo H; Lin W; Brooks JG; Lippard SJ
J Am Chem Soc; 2014 Jun; 136(24):8790-8. PubMed ID: 24902769
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen
Ravera M; Zanellato I; Gabano E; Perin E; Rangone B; Coppola M; Osella D
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31238499
[TBL] [Abstract][Full Text] [Related]
10. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.
Johnstone TC; Suntharalingam K; Lippard SJ
Chem Rev; 2016 Mar; 116(5):3436-86. PubMed ID: 26865551
[TBL] [Abstract][Full Text] [Related]
11. Copper-free click-chemistry platform to functionalize cisplatin prodrugs.
Pathak RK; McNitt CD; Popik VV; Dhar S
Chemistry; 2014 Jun; 20(23):6861-5. PubMed ID: 24756923
[TBL] [Abstract][Full Text] [Related]
12. Nuclear-Targeting Lipid Pt
Wei D; Fan J; Yan J; Liu C; Cao J; Xu C; Sun Y; Xiao H
J Am Chem Soc; 2024 Jan; 146(1):1185-1195. PubMed ID: 38148611
[TBL] [Abstract][Full Text] [Related]
13. Endowing Pt(IV) with Perfluorocarbon Chains and Human Serum Albumin Encapsulation for Highly Effective Antitumor Chemoimmunotherapy.
Xie P; Jin Q; Zhang L; Zhang H; Montesdeoca N; Karges J; Xiao H; Mao X; Song H; Shang K
ACS Nano; 2024 May; 18(21):13683-13695. PubMed ID: 38749906
[TBL] [Abstract][Full Text] [Related]
14. Adenine-adenine, adenine-cytosine and cytosine-cytosine intrastrand crosslinks induced by a photoactivatable Pt(IV) anticancer prodrug.
Lin J; Huang J; Zhang J; Qin X; Ma Z; Wu X; Wang F; Zhao Y; Wu K
Dalton Trans; 2023 Dec; 53(1):292-298. PubMed ID: 38047479
[TBL] [Abstract][Full Text] [Related]
15. Gemfibrozil-Platinum(IV) Precursors for New Enhanced-Starvation and Chemotherapy In Vitro and In Vivo.
Song XQ; Guo X; Ding YX; Han YX; You ZH; Song Y; Yuan Y; Li L
J Med Chem; 2024 May; 67(9):7033-7047. PubMed ID: 38634331
[TBL] [Abstract][Full Text] [Related]
16. Oxamusplatin: a cytotoxic Pt(ii) complex of a nitrogen mustard with resistance to thiol based sequestration displays enhanced selectivity towards cancer.
Maji M; Karmakar S; Ruturaj ; Gupta A; Mukherjee A
Dalton Trans; 2020 Feb; 49(8):2547-2558. PubMed ID: 32022814
[TBL] [Abstract][Full Text] [Related]
17. Highly photoactive Ir(III)-Pt(IV) heterometallic conjugates for anticancer therapy.
Hu W; Liu R; Zheng K; Wang Z
Chem Commun (Camb); 2024 Jan; 60(4):388-391. PubMed ID: 38054250
[TBL] [Abstract][Full Text] [Related]
18. Single-Cell ICP-MS in Combination with Fluorescence-Activated Cell Sorting for Investigating the Effects of Nanotransported Cisplatin(IV) Prodrugs.
Gutierrez-Romero L; Blanco-González E; Montes-Bayón M
Anal Chem; 2023 Aug; 95(32):11874-11878. PubMed ID: 37535006
[TBL] [Abstract][Full Text] [Related]
19. A Dogma in Doubt: Hydrolysis of Equatorial Ligands of Pt
Kastner A; Poetsch I; Mayr J; Burda JV; Roller A; Heffeter P; Keppler BK; Kowol CR
Angew Chem Int Ed Engl; 2019 May; 58(22):7464-7469. PubMed ID: 30870571
[TBL] [Abstract][Full Text] [Related]
20. Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands.
Li X; Liu Y; Tian H
Bioinorg Chem Appl; 2018; 2018():8276139. PubMed ID: 30402082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
